» Articles » PMID: 16107141

Discovery of Substituted Maleimides As Liver X Receptor Agonists and Determination of a Ligand-bound Crystal Structure

Abstract

Substituted 3-(phenylamino)-1H-pyrrole-2,5-diones were identified from a high throughput screen as inducers of human ATP binding cassette transporter A1 expression. Mechanism of action studies led to the identification of GSK3987 as an LXR ligand. GSK3987 recruits the steroid receptor coactivator-1 to human LXRalpha and LXRbeta with EC(50)s of 40 nM, profiles as an LXR agonist in functional assays, and activates LXR though a mechanism that is similar to first generation LXR agonists.

Citing Articles

Liver X Receptors (LXRs) in cancer-an Eagle's view on molecular insights and therapeutic opportunities.

Ramalingam P, Elangovan S, Mekala J, Arumugam S Front Cell Dev Biol. 2024; 12:1386102.

PMID: 38550382 PMC: 10972936. DOI: 10.3389/fcell.2024.1386102.


Ligands of Therapeutic Utility for the Liver X Receptors.

Komati R, Spadoni D, Zheng S, Sridhar J, Riley K, Wang G Molecules. 2017; 22(1).

PMID: 28067791 PMC: 5373669. DOI: 10.3390/molecules22010088.


Nuclear Receptor NR1H3 in Familial Multiple Sclerosis.

Wang Z, Sadovnick A, Traboulsee A, Ross J, Bernales C, Encarnacion M Neuron. 2016; 90(5):948-54.

PMID: 27253448 PMC: 5092154. DOI: 10.1016/j.neuron.2016.04.039.


Styrylphenylphthalimides as Novel Transrepression-Selective Liver X Receptor (LXR) Modulators.

Nomura S, Endo-Umeda K, Aoyama A, Makishima M, Hashimoto Y, Ishikawa M ACS Med Chem Lett. 2015; 6(8):902-7.

PMID: 26288691 PMC: 4538439. DOI: 10.1021/acsmedchemlett.5b00170.


Identification of novel liver X receptor activators by structure-based modeling.

von Grafenstein S, Mihaly-Bison J, Wolber G, Bochkov V, Liedl K, Schuster D J Chem Inf Model. 2012; 52(5):1391-400.

PMID: 22489742 PMC: 3360526. DOI: 10.1021/ci300096c.